Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial.

NCT06342544 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

128

Enrollment

NETWORK

Sponsor class

Conditions

Ocular Myasthenia Gravis

Interventions

DRUG: immediate treatment with corticosteroids
DRUG: addition of rituximab if recurrence

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild